Noriko Oza

1.1k total citations
24 papers, 397 citations indexed

About

Noriko Oza is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Noriko Oza has authored 24 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Hepatology and 3 papers in Oncology. Recurrent topics in Noriko Oza's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (12 papers) and Hepatitis B Virus Studies (4 papers). Noriko Oza is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (12 papers) and Hepatitis B Virus Studies (4 papers). Noriko Oza collaborates with scholars based in Japan, India and Singapore. Noriko Oza's co-authors include Yuichiro Eguchi, Toshihiko Mizuta, Iwata Ozaki, Yasunori Kawaguchi, Hiroshi Isoda, Kazuhiro Takahashi, Tatsuya Kanto, Yoichiro Kitajima, Shunya Nakashita and Takuya Kuwashiro and has published in prestigious journals such as Gastroenterology, Digestive Diseases and Sciences and Journal of Gastroenterology and Hepatology.

In The Last Decade

Noriko Oza

21 papers receiving 390 citations

Peers

Noriko Oza
Muhammad Y. Sheikh United States
Rebecca Harris United Kingdom
Abbey Barnard United States
Alex Zimmet United States
Mona Lalehzari United States
Noriko Oza
Citations per year, relative to Noriko Oza Noriko Oza (= 1×) peers Tomomi Okubo

Countries citing papers authored by Noriko Oza

Since Specialization
Citations

This map shows the geographic impact of Noriko Oza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Oza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Oza more than expected).

Fields of papers citing papers by Noriko Oza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Oza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Oza. The network helps show where Noriko Oza may publish in the future.

Co-authorship network of co-authors of Noriko Oza

This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Oza. A scholar is included among the top collaborators of Noriko Oza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Oza. Noriko Oza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Youxin, Noriko Oza, Sakkarin Chirapongsathorn, et al.. (2025). Rising burden of metabolic dysfunction-associated steatotic liver disease in adolescents aged 15–19 years and projections to 2035. Diabetes Research and Clinical Practice. 230. 113004–113004.
2.
Nakashita, Shunya, et al.. (2024). [Case of Acute Pancreatitis during Eribulin Mesilate Therapy for Metastasis of Breast Cancer].. PubMed. 51(9). 955–957.
3.
Shimakami, Tetsuro, Hiroko Setoyama, Noriko Oza, et al.. (2023). Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan. Journal of Gastroenterology. 58(3). 257–267. 2 indexed citations
4.
Itakura, Jun, Masayuki Kurosaki, Hiroko Setoyama, et al.. (2021). Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis. Journal of Gastroenterology. 56(5). 470–478. 32 indexed citations
6.
Hiraki, Masatsugu, Toshiya Tanaka, Noriko Oza, et al.. (2019). An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report. Journal of Gastrointestinal Cancer. 51(1). 296–299. 1 indexed citations
8.
Tanaka, Kenichi, Hirokazu Takahashi, Hideyuki Hyogo, et al.. (2018). Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non‐alcoholic fatty liver disease. Hepatology Research. 49(3). 296–303. 30 indexed citations
10.
Kuwashiro, Takuya, Toshihiko Mizuta, Yasunori Kawaguchi, et al.. (2013). Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance. Journal of Gastroenterology. 49(2). 317–323. 6 indexed citations
11.
Oeda, Satoshi, Toshihiko Mizuta, Hiroshi Isoda, et al.. (2012). Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis. Clinical Journal of Gastroenterology. 5(2). 141–145. 4 indexed citations
12.
Takahashi, Kazuhiro, Toshihiko Mizuta, Yuichiro Eguchi, et al.. (2011). Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C. Journal of Gastroenterology. 46(6). 790–798. 33 indexed citations
13.
Kawaguchi, Yasunori, Toshihiko Mizuta, Takuya Kuwashiro, et al.. (2010). Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C. Journal of Gastroenterology. 46(4). 529–535. 12 indexed citations
14.
Ario, Keisuke, Toshihiko Mizuta, Yuichiro Eguchi, et al.. (2010). Presence of esophageal varices is a risk factor for non-hemorrhagic death of hepatocellular carcinoma patients treated with radiofrequency ablation.. PubMed. 57(99-100). 501–6. 1 indexed citations
15.
Kawaguchi, Yasunori, Toshihiko Mizuta, Noriko Oza, et al.. (2009). Eradication of hepatitis C virus by interferon improves whole‐body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C. Liver International. 29(6). 871–877. 31 indexed citations
16.
Mizuta, Toshihiko, Yasunori Kawaguchi, Yuichiro Eguchi, et al.. (2009). Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load. Digestive Diseases and Sciences. 55(1). 183–189. 21 indexed citations
17.
Oza, Noriko, Yuichiro Eguchi, Toshihiko Mizuta, et al.. (2009). A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. Journal of Gastroenterology. 44(12). 1203–1208. 68 indexed citations
18.
Eguchi, Yuichiro, Toshihiko Mizuta, Yoichiro Kitajima, et al.. (2009). Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation. Liver International. 29(2). 213–220. 28 indexed citations
20.
Eguchi, Yuichiro, Takahisa Eguchi, Noriko Oza, et al.. (2008). Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non‐alcoholic fatty liver disease, but not in females. Journal of Gastroenterology and Hepatology. 23(6). 908–913. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026